Diminished Expression of Galectin-3 Around Blisters in Bullous Pemphigoid: An Immunohistochemistry Study

Background: Bullous pemphigoid (BP) is a subepidermal blistering disorder caused by autoantibodies directed against hemidesmosomal proteins. Many patients with BP demonstrate circulating IgE autoantibodies. Although the role of IgE in the pathogenesis of BP is unknown, a correlation between IgE ant...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maryam Aghighi, Bruce Smoller
Formato: article
Lenguaje:EN
Publicado: Mattioli1885 2020
Materias:
Acceso en línea:https://doaj.org/article/f18016d713f74b3f87f34d4648ba47ed
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f18016d713f74b3f87f34d4648ba47ed
record_format dspace
spelling oai:doaj.org-article:f18016d713f74b3f87f34d4648ba47ed2021-11-17T08:28:26ZDiminished Expression of Galectin-3 Around Blisters in Bullous Pemphigoid: An Immunohistochemistry Study10.5826/dpc.1004a1062160-9381https://doaj.org/article/f18016d713f74b3f87f34d4648ba47ed2020-10-01T00:00:00Zhttp://dpcj.org/index.php/dpc/article/view/1340https://doaj.org/toc/2160-9381 Background: Bullous pemphigoid (BP) is a subepidermal blistering disorder caused by autoantibodies directed against hemidesmosomal proteins. Many patients with BP demonstrate circulating IgE autoantibodies. Although the role of IgE in the pathogenesis of BP is unknown, a correlation between IgE antibodies and eosinophilia has been observed. Soluble CD23 and galectin-3 are the main elements of the IgE group. The roles for CD23 in BP as a potential biomarker and IgE production regulator have been characterized, but no studies have evaluated any roles for galectin-3 in this disease. Objectives: In this study, we evaluated galectin-3 expression in BP as a first step in assessing its role in the pathogenesis of this autoimmune blistering process.  Patients and Methods: Sixty specimens diagnosed as BP were stained with antibodies to galectin-3. The percentages of nuclear and cytoplasmic galectin-3 expression and staining intensity were evaluated. Results: There was a significant difference in galectin-3 cytoplasmic and nuclear expression within keratinocytes immediately surrounding and above the blisters: (1) cytoplasmic (mean = 17.2% ± 2.4%) vs adjacent unaffected skin (mean = 66.7% ± 2.0%, P < 0.0001) and (2) nuclear (mean = 1.9% ± 0.4%) vs adjacent unaffected skin (mean = 13.2% ± 1.2%, P < 0.0001). Conclusions: Lower expression of galectin-3 around blisters in BP may suggest a role as an adhesion molecule. Loss of galectin-3 may add to the extension of blister formation by initiating cell-extracellular matrix disassembly and may be involved with the associated dermal inflammation and the eosinophil chemotaxis. Further studies will be necessary to elucidate the result of this observed loss on disease pathogenesis. Maryam AghighiBruce SmollerMattioli1885articlebullous pemphigoidgalectin-3blister formationDermatologyRL1-803ENDermatology Practical & Conceptual, Vol 10, Iss 4 (2020)
institution DOAJ
collection DOAJ
language EN
topic bullous pemphigoid
galectin-3
blister formation
Dermatology
RL1-803
spellingShingle bullous pemphigoid
galectin-3
blister formation
Dermatology
RL1-803
Maryam Aghighi
Bruce Smoller
Diminished Expression of Galectin-3 Around Blisters in Bullous Pemphigoid: An Immunohistochemistry Study
description Background: Bullous pemphigoid (BP) is a subepidermal blistering disorder caused by autoantibodies directed against hemidesmosomal proteins. Many patients with BP demonstrate circulating IgE autoantibodies. Although the role of IgE in the pathogenesis of BP is unknown, a correlation between IgE antibodies and eosinophilia has been observed. Soluble CD23 and galectin-3 are the main elements of the IgE group. The roles for CD23 in BP as a potential biomarker and IgE production regulator have been characterized, but no studies have evaluated any roles for galectin-3 in this disease. Objectives: In this study, we evaluated galectin-3 expression in BP as a first step in assessing its role in the pathogenesis of this autoimmune blistering process.  Patients and Methods: Sixty specimens diagnosed as BP were stained with antibodies to galectin-3. The percentages of nuclear and cytoplasmic galectin-3 expression and staining intensity were evaluated. Results: There was a significant difference in galectin-3 cytoplasmic and nuclear expression within keratinocytes immediately surrounding and above the blisters: (1) cytoplasmic (mean = 17.2% ± 2.4%) vs adjacent unaffected skin (mean = 66.7% ± 2.0%, P < 0.0001) and (2) nuclear (mean = 1.9% ± 0.4%) vs adjacent unaffected skin (mean = 13.2% ± 1.2%, P < 0.0001). Conclusions: Lower expression of galectin-3 around blisters in BP may suggest a role as an adhesion molecule. Loss of galectin-3 may add to the extension of blister formation by initiating cell-extracellular matrix disassembly and may be involved with the associated dermal inflammation and the eosinophil chemotaxis. Further studies will be necessary to elucidate the result of this observed loss on disease pathogenesis.
format article
author Maryam Aghighi
Bruce Smoller
author_facet Maryam Aghighi
Bruce Smoller
author_sort Maryam Aghighi
title Diminished Expression of Galectin-3 Around Blisters in Bullous Pemphigoid: An Immunohistochemistry Study
title_short Diminished Expression of Galectin-3 Around Blisters in Bullous Pemphigoid: An Immunohistochemistry Study
title_full Diminished Expression of Galectin-3 Around Blisters in Bullous Pemphigoid: An Immunohistochemistry Study
title_fullStr Diminished Expression of Galectin-3 Around Blisters in Bullous Pemphigoid: An Immunohistochemistry Study
title_full_unstemmed Diminished Expression of Galectin-3 Around Blisters in Bullous Pemphigoid: An Immunohistochemistry Study
title_sort diminished expression of galectin-3 around blisters in bullous pemphigoid: an immunohistochemistry study
publisher Mattioli1885
publishDate 2020
url https://doaj.org/article/f18016d713f74b3f87f34d4648ba47ed
work_keys_str_mv AT maryamaghighi diminishedexpressionofgalectin3aroundblistersinbullouspemphigoidanimmunohistochemistrystudy
AT brucesmoller diminishedexpressionofgalectin3aroundblistersinbullouspemphigoidanimmunohistochemistrystudy
_version_ 1718425838431502336